Literature DB >> 25173806

Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.

Yadong Huang1, Robert W Mahley2.   

Abstract

Apolipoprotein (apo) E is a multifunctional protein with central roles in lipid metabolism, neurobiology, and neurodegenerative diseases. It has three major isoforms (apoE2, apoE3, and apoE4) with different effects on lipid and neuronal homeostasis. A major function of apoE is to mediate the binding of lipoproteins or lipid complexes in the plasma or interstitial fluids to specific cell-surface receptors. These receptors internalize apoE-containing lipoprotein particles; thus, apoE participates in the distribution/redistribution of lipids among various tissues and cells of the body. In addition, intracellular apoE may modulate various cellular processes physiologically or pathophysiologically, including cytoskeletal assembly and stability, mitochondrial integrity and function, and dendritic morphology and function. Elucidation of the functional domains within this protein and of the three-dimensional structure of the major isoforms of apoE has contributed significantly to our understanding of its physiological and pathophysiological roles at a molecular level. It is likely that apoE, with its multiple cellular origins and multiple structural and biophysical properties, is involved widely in processes of lipid metabolism and neurobiology, possibly encompassing a variety of disorders of neuronal repair, remodeling, and degeneration by interacting with different factors through various pathways.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; ApoE; Lipid metabolism; Mouse model

Mesh:

Substances:

Year:  2014        PMID: 25173806      PMCID: PMC4253862          DOI: 10.1016/j.nbd.2014.08.025

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  150 in total

1.  Apolipoprotein E and cognitive performance.

Authors:  J Raber; D Wong; G Q Yu; M Buttini; R W Mahley; R E Pitas; L Mucke
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

2.  Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.

Authors:  K Kamino; K Nagasaka; M Imagawa; H Yamamoto; H Yoneda; A Ueki; S Kitamura; K Namekata; T Miki; S Ohta
Journal:  Biochem Biophys Res Commun       Date:  2000-06-24       Impact factor: 3.575

3.  Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.

Authors:  D M Holtzman; A M Fagan; B Mackey; T Tenkova; L Sartorius; S M Paul; K Bales; K H Ashe; M C Irizarry; B T Hyman
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

Review 4.  Apolipoprotein E: structure-function relationships.

Authors:  K H Weisgraber
Journal:  Adv Protein Chem       Date:  1994

5.  The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization.

Authors:  B P Nathan; K C Chang; S Bellosta; E Brisch; N Ge; R W Mahley; R E Pitas
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

6.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.

Authors:  B P Nathan; S Bellosta; D A Sanan; K H Weisgraber; R W Mahley; R E Pitas
Journal:  Science       Date:  1994-05-06       Impact factor: 47.728

7.  Isoform-specific binding of apolipoprotein E to beta-amyloid.

Authors:  M J LaDu; M T Falduto; A M Manelli; C A Reardon; G S Getz; D E Frail
Journal:  J Biol Chem       Date:  1994-09-23       Impact factor: 5.157

8.  Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

Authors:  R Mayeux; R Ottman; G Maestre; C Ngai; M X Tang; H Ginsberg; M Chun; B Tycko; M Shelanski
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

9.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; M Goedert; K H Weisgraber; L M Dong; R Jakes; D Y Huang; M Pericak-Vance; D Schmechel; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

Review 10.  Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.

Authors:  W J Strittmatter; K H Weisgraber; M Goedert; A M Saunders; D Huang; E H Corder; L M Dong; R Jakes; M J Alberts; J R Gilbert
Journal:  Exp Neurol       Date:  1994-02       Impact factor: 5.330

View more
  176 in total

1.  Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.

Authors:  Jinmei Luo; Junli Song; Pinning Feng; Yanhong Wang; Weiqing Long; Min Liu; Laisheng Li
Journal:  Tumour Biol       Date:  2016-02-12

Review 2.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

3.  Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients.

Authors:  Erdinç Dursun; Merve Alaylıoğlu; Başar Bilgiç; Haşmet Hanağası; Ebba Lohmann; Irem L Atasoy; Esin Candaş; Ömür Selin Araz; Burak Önal; Hakan Gürvit; Selma Yılmazer; Duygu Gezen-Ak
Journal:  Neurol Sci       Date:  2016-06-29       Impact factor: 3.307

4.  Genetic Determinants of Dyslipidemia in African-Based Populations: A Systematic Review.

Authors:  Jean Jacques Noubiap; Edith Pascale M Mato; Magellan Guewo-Fokeng; Arnaud D Kaze; Houssam Boulenouar; Ambroise Wonkam
Journal:  OMICS       Date:  2018-12

5.  Effect of ApoE4 Genotype on the Association Between Metabolic Phenotype and Subclinical Atherosclerosis in Postmenopausal Women.

Authors:  Intira Sriprasert; Wendy Jean Mack; Howard Neil Hodis; Hooman Allayee; Roberta Diaz Brinton; Roksana Karim
Journal:  Am J Cardiol       Date:  2019-07-15       Impact factor: 2.778

6.  Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease.

Authors:  Benoit Lehallier; Laurent Essioux; Javier Gayan; Roxana Alexandridis; Tania Nikolcheva; Tony Wyss-Coray; Markus Britschgi
Journal:  JAMA Neurol       Date:  2015-12-14       Impact factor: 18.302

Review 7.  Alzheimer Disease: Scientific Breakthroughs and Translational Challenges.

Authors:  Richard J Caselli; Thomas G Beach; David S Knopman; Neill R Graff-Radford
Journal:  Mayo Clin Proc       Date:  2017-06       Impact factor: 7.616

8.  High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia.

Authors:  Dustin Chernick; Stephanie Ortiz-Valle; Angela Jeong; Suresh K Swaminathan; Karunya K Kandimalla; G William Rebeck; Ling Li
Journal:  J Neurochem       Date:  2018-11-26       Impact factor: 5.372

9.  Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol.

Authors:  P Alvarez; F Genre; M Iglesias; J J Augustin; E Tamayo; J C Escolà-Gil; B Lavín; F Blanco-Vaca; R Merino; J Merino
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

Review 10.  Late-onset Alzheimer Disease.

Authors:  Gil D Rabinovici
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.